Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Starr's findings account for some of the 19% black-white gap in federal sentencing

Frey says suburbs are aging, cities draw millennials

Pfeffer comments on Fed report that reveals 20-year decline in net worth among American families

More News

Highlights

U-M's campus climate survey results discussed in CHE story

U-M honors James Jackson's groundbreaking work on how race impacts the health of black Americans

U-M is the only public and non-coastal university on Forbes' top-10 list for billionaire production

ASA President Bonilla-Silva takes exception with Chief Justice Roberts' 'gobbledygook' jab

More Highlights

Next Brown Bag

Mon, Jan 22, 2018, noon: Narayan Sastry

Prostate Cancer Screening Decisions Results From the National Survey of Medical Decisions (DECISIONS Study)

Publication Abstract

Hoffman, R.M., Mick P. Couper, B.J. Zikmund-Fisher, C.A. Levin, M. McNaughton-Collins, D.L. Helitzer, J. VanHoewyk, and M.J. Barry. 2009. "Prostate Cancer Screening Decisions Results From the National Survey of Medical Decisions (DECISIONS Study)." Archives of Internal Medicine, 169(17): 1611-1618.

Background: Guidelines recommend informing patients about the risks and benefits of prostate cancer screening. We evaluated the medical decision-making process for prostate-specific antigen (PSA) testing. Methods: We conducted a telephone survey of a randomly selected national sample of 3010 English-speaking US adults 40 years and older. Included in the survey were 375 men who had either undergone or discussed (with health care providers [HCPs]) PSA testing in the previous 2 years. We asked subjects about socio-demographic characteristics, prostate cancer screening discussion features, prostate cancer knowledge, and the importance of various decision factors and sources of information. Results: Overall, 69.9% of subjects discussed screening before making a testing decision, including 14.4% who were not tested. Health care providers most often (64.6%) raised the idea of screening, and 73.4% recommended PSA testing. Health care providers emphasized the pros of testing in 71.4% of discussions but infrequently addressed the cons (32.0%). Although 58.0% of subjects felt well-informed about PSA testing, 47.8% failed to correctly answer any of the 3 knowledge questions. Only 54.8% of subjects reported being asked for their screening preferences. An HCP recommendation (odds ratio, 2.67; 95% confidence interval, 1.08-6.58) was the only discussion characteristic associated with testing. Valuing HCP information was also associated with testing (odds ratio, 1.26; 95% confidence interval, 1.04-1.54). Conclusions: Recommendations and information from HCPs strongly influenced testing decisions. However, most prostate cancer screening decisions did not meet criteria for shared decision making because subjects did not receive balanced discussions of decision consequences, had limited knowledge, and were not routinely asked for their preferences.

Country of focus: United States of America.

Browse | Search : All Pubs | Next